- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Charming Medical Limited Class A Ordinary Shares(MCTA)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for MCTA
11/13/2026: MCTA (1-star) is currently NOT-A-BUY. Pass it for now.
Charming Medical Limited is a micro-cap wellness and beauty service provider operating entirely within Hong Kong under the ticker MCTA. The company integrates traditional Chinese medicine practices with modern therapeutic concepts through physical centers and its proprietary Beauty Lab product lines. Its primary investment story centers on capturing niche consumer demand for holistic women's health and postpartum care, supported by asset-light expansion opportunities in franchising. However, key risks include localized revenue concentration in Hong Kong, micro-cap share volatility, thin trading liquidity, and recent compliance notices from the exchange. The stock suits risk-tolerant momentum or speculative investors who monitor regulatory updates and regional consumer trends closely.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Weak fit | Modest top-line revenue growth and a micro-cap profile offer limited scale for aggressive growth strategies. |
| Momentum investor | Strong fit while signal remains positive | Low float dynamics can occasionally produce sharp technical price movements conditional on a positive upturn signal. |
| Value investor | Mixed fit | Unpredictable profitability and sparse earnings history make traditional valuation modeling difficult. |
| Dividend investor | Weak fit | The company does not pay dividends, offering no current income return. |
| Low-risk investor | Weak fit | Micro-cap volatility, liquidity constraints, and regulatory listing notices present high risk for conservative investors. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | Thin trading volume and small market capitalization lead to exaggerated daily price swings. |
| Valuation risk | Medium / high | Earnings instability makes fundamental valuation benchmarks challenging to ascertain. |
| Competition risk (localized wellness market competition) | High | Low barriers to entry in local beauty and wellness services intensify pricing pressure. |
| Business quality | Medium | Niche TCM integration provides customer loyalty but remains constrained by geographic limits. |
| Dividend income | Low / none | No payouts are distributed to shareholders. |
| Execution risk | Medium / high | Success relies heavily on key management execution and retail consumer sentiment in Hong Kong. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 445.55M USD | Price to earnings Ratio 419.36 | 1Y Target Price - |
Price to earnings Ratio 419.36 | 1Y Target Price - | ||
Volume (30-day avg) - shares | Beta - | 52 Weeks Range 29.36 - 29.36 | Updated Date 11/15/2026 |
52 Weeks Range 29.36 - 29.36 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.07 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Care Facilities
- BUY participation
- 88.9%
- Active BUY / eligible
- 8 / 9
- 30-Day BUY Count Change
- +6
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Flat / Range-Bound
The stock price has been trading within a narrow range with minimal directional movement.

Very Smooth
The stock has followed a highly orderly price path with minimal short-term disruption.
Analysis of Past Performance
Type Stock | Historic Profit 0% | Avg. Invested days 0 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Wellness & Beauty Services | In-person therapeutic treatments, postpartum care, and facial adjustments conducted across wellness centers. | This is the primary revenue foundation derived directly from local service appointments. |
| Retail Product Sales | E-commerce and center-based sales of skincare, intimate care, and herbal supplements under the Beauty Lab brand. | Provides supplementary high-margin product revenue streams alongside physical services. |
| Geography (Hong Kong) | All physical centers and client base operations concentrated entirely within Hong Kong. | Exposes business performance directly to regional economic conditions in Hong Kong. |
Valuation
Trailing PE 419.36 | Forward PE - | Enterprise Value 502.66M | Price to Sales(TTM) 92.67 |
Enterprise Value 502.66M | Price to Sales(TTM) 92.67 | ||
Enterprise Value to Revenue 80.79 | Enterprise Value to EBITDA 292.33 | Shares Outstanding 15.18M | Shares Floating 5.46M |
Shares Outstanding 15.18M | Shares Floating 5.46M | ||
Percent Insiders 68.19 | Percent Institutions 0.23 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

